1. Home
  2. CLPT vs TOI Comparison

CLPT vs TOI Comparison

Compare CLPT & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ClearPoint Neuro Inc.

CLPT

ClearPoint Neuro Inc.

HOLD

Current Price

$14.12

Market Cap

451.3M

Sector

Health Care

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$4.95

Market Cap

565.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLPT
TOI
Founded
1998
2007
Country
United States
United States
Employees
N/A
641
Industry
Medical/Dental Instruments
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
451.3M
565.9M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
CLPT
TOI
Price
$14.12
$4.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$20.00
$6.67
AVG Volume (30 Days)
580.5K
2.2M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,971,000.00
N/A
Revenue This Year
$45.67
$30.15
Revenue Next Year
$19.51
$25.77
P/E Ratio
N/A
N/A
Revenue Growth
17.78
N/A
52 Week Low
$8.27
$2.32
52 Week High
$30.10
$6.67

Technical Indicators

Market Signals
Indicator
CLPT
TOI
Relative Strength Index (RSI) 38.38 43.73
Support Level $13.38 $4.90
Resistance Level $15.09 $5.63
Average True Range (ATR) 0.79 0.42
MACD -0.46 -0.12
Stochastic Oscillator 7.03 2.11

Price Performance

Historical Comparison
CLPT
TOI

About CLPT ClearPoint Neuro Inc.

ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

Share on Social Networks: